UnknownNCT03903393
Serum LncRNAs as Early Potential Biomarkers for the Prediction of Preeclampsia
Studying Preeclampsia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- First Affiliated Hospital of Harbin Medical University
- Principal Investigator
- Yue LiFirst Affiliated Hospital of Harbin Medical University
- Enrollment
- 260 target
- Eligibility
- 20-45 years · FEMALE
- Timeline
- 2019 – 2021
Study locations (1)
- Serum LncRNAs as Potential Biomarkers for the Prediction of Preeclampsia, Harbin, Heilongjiang, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03903393 on ClinicalTrials.govOther trials for Preeclampsia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07443345Incidence of Postoperative Diaphragmatic Dysfunction in Pregnant Women With PreeclampsiaCairo University
- RECRUITINGPHASE2NCT06333652Ravulizumab in Pregnancies Complicated by Severe Hypertensive DisordersMayo Clinic
- RECRUITINGNANCT07245056Fetal Fornix and Hippocampus in Pregnant Women With Early-Onset PreeclampsiaAnkara Etlik City Hospital
- RECRUITINGPHASE2NCT07041281Spironolactone to Improve Pregnancy-Associated Hypertension TrajectoriesMassachusetts General Hospital
- RECRUITINGNCT07485140Prevention of Preeclampsia in Denmark: A National Implementation StudyCopenhagen University Hospital at Herlev
- RECRUITINGNANCT06893510Virtual Reality-Based and Face-to-Face Relaxation Programs in Pregnant Women With PreeclampsiaIstanbul University - Cerrahpasa
- RECRUITINGNANCT07261956Lung Ultrasound for the Detection of Volume Overload in Patients With Severe PreeclampsiaSaint Thomas Hospital, Panama
- RECRUITINGNANCT07265336Excess Base Comparison Between Pregnant Subjects With Severe Preeclampsia vs. Normotensive Pregnant WomenSaint Thomas Hospital, Panama